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Endovascular treatment (EVT) has become a standard treatment for acute ischemic
stroke due to large vessel occlusion (LVO) in the anterior circulation. However, whether
EVT tools used for intracranial atherosclerotic stenosis (ICAS)-related LVO are as safe
and effective as for use in embolic LVO remains unclear. There have been only a few
studies about EVT for ICAS-related LVO, and these studies revealed that mechanical
thrombectomy with a stent retriever or contact aspiration was less effective and more
time consuming in ICAS-related LVO than in embolic LVO. Because fast and successful
recanalization (defined as modified Thrombolysis in Cerebral Ischemia grade, 2b or 3) is
the most critical factor influencing favorable outcomes, it is important to determine the
appropriate EVT strategy for fast recanalization of ICAS-related LVO. In this report, we
review the results of mechanical thrombectomy using stent retriever or contact aspiration
and rescue treatments after failure of mechanical thrombectomy for ICAS-related LVO.
Finally, we propose the EVT strategy appropriate for ICAS-related LVO based on a
literature review and our experience.
Keywords: acute stroke, large vessel occlusion, intracranial atherosclerosis, endovascular treatment, stenosis
and cerebrovascular occlusion
INTRODUCTION
Endovascular treatment (EVT) for acute stroke due to emergent large vessel occlusion (LVO) has
been successful, and EVT has become a standard treatment for LVO (1). The rate of recanalization,
defined as modified Thrombolysis In Cerebral Ischemia (mTICI) grade 2b or 3, has been
improving since the first 5 successful EVT trials, which demonstrated that higher recanalization
rates are associated with better clinical outcomes (2–5). For mechanical thrombectomy, the
two mainstay modalities are stent retriever (SR) and contact aspiration (CA) thrombectomies.
Both methods were primarily invented for removal of the embolic clots occluding the large
vessel. The pathomechanism of intracranial atherosclerosis (ICAS)-related LVO is likely due to
in-situ thromboocclusion rather than embolic occlusion (6–8). The efficacy of both methods for
recanalization of in-situ thromboocclusion in ICAS-related LVO has not been well elucidated.
ICAS is one of the main causes of acute stroke in Asian, Hispanic, and African populations
(9–11) and furthermore recent studies have documented that ICAS-related LVO is responsible for
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approximately 12–30% of all causes of LVO in East Asia (7, 8, 12–
16). Therefore, it is worthwhile to investigate the efficacy of SR
or CA thrombectomy and the most appropriate EVT strategy for
ICAS-related LVO. This review aims to investigate on what are
the problems in EVT and to find out the appropriate treatment
strategy for ICAS-related LVO.
OUTCOMES OF ENDOVASCULAR
TREATMENT FOR ICAS-RELATED LVO
Until recently, there have been only a few retrospective studies
in which the clinical outcomes of EVT for ICAS-related LVO
have been evaluated, and the results were inconsistent. In a
study, patients with ICAS-related LVO had more favorable
outcomes than patients with embolic LVO (15). In contrast,
other researchers showed less favorable outcomes or no
significant difference between the two groups (8, 14, 16–18).
Notably, the rate of favorable outcomes was proportionate to
the recanalization success rate. Successful recanalization and
favorable outcome rates were observed more frequently in
patients with ICAS-related LVO in a few reports, but the opposite
was observed in a different study. In another study with similar
recanalization rates, clinical outcomes were similar between the
two groups (Table 1).
In a recent study, ICAS-related LVO was a worse prognostic
factor in multivariate analysis although recanalization rates
were similar between embolic and ICAS-related LVO groups.
A significant interaction of underlying etiology (ICAS verse
embolic) on patient outcome was observed with procedure
(puncture-o-recanalization) time. Therefore, they suggested that
“the relatively poor outcome in the ICAS-related LVO is mainly
attributable to longer procedure time, reflecting the procedure
complexity and the higher rate of reocclusion” (19).
From the results of the previous studies, we can infer
that recanalization status and procedural time (puncture-to-
recanalization time) are more relevant factors affecting patient
outcomes than occlusion etiology itself (ICAS vs. embolic). In
other words, if successful recanalization in the ICAS-related LVO
was achieved as fast and with high rate as in the embolic LVO,
functional outcome of ICAS-related LVO would be comparable
to that of embolic LVO.
ENDOVASCULAR TREATMENT FOR
ICAS-RELATED LVO
Stent Retriever Thrombectomy for
ICAS-Related Large Vessel Occlusion
SR thrombectomy is recommended as the first-line EVTmodality
for acute stroke due to anterior circulation LVO (1). SR
thrombectomy for obtaining initial recanalization appeared to be
as effective in ICAS-related LVO as in embolic LVO (6, 7, 12–
16, 19). However, reocclusion during EVT is very frequent after
an initial recanalization with SR thrombectomy in ICAS-related
LVO, with reported ranges from 57.1 to 77.3% (6, 7, 12–16).
For SR thrombectomy, a microwire should be passed through
the occlusion site followed by a microcatheter with an inner
diameter ≥0.021-inch. Although physicians may be concerned
that passage of a microwire followed by a microcatheter is
potentially dangerous, the initial SR attempt was successful in
most ICAS-related LVO cases, and has not been reported to be
difficult (6, 7, 13–15). However, once reocclusion occurs, repeated
SR thrombectomy attempt seemed to be ineffective and prone
to procedural complications because it may cause vessel injury,
resulting in repeat reocclusion, spasm, and dissection (6, 7, 13–
16, 20, 22, 23).
Although it has not yet been well known why reocclusion
is so frequent in ICAS-related LVO, it can be explained
by its pathomechanism and thrombectomy procedure itself.
The pathomechanism of ICAS-related LVO, similar to that of
coronary artery disease, is likely in-situ thromboocclusion due
to unstable plaque rupture (6–8). An acute in-situ clot formed
on an ICAS plaque is platelet-rich one (22). Repeat passages of
a microwire, a microcatheter and SR may further damage the
inflamed plaque and thus provoke more platelet activation and
even arterial dissection (Figure 1) (6, 7, 21). Therefore, repeat
attempts of SR thrombectomy should be avoided so far as possible
once reocclusion has occurred in ICAS-related LVO (6, 7, 13, 14).
Contact Aspiration Thrombectomy for
ICAS-Related Large Vessel Occlusion
Although first-line CA thrombectomy is as effective as SR
thrombectomy in embolic LVO, it seemed less effective for
recanalization of ICAS-related LVO. In a study that compared the
efficacy of SR vs. CA thrombectomy in 146 ICAS-related LVO,
the rate of switching to alternative thrombectomy technique (SR
to CA thrombectomy or vice versa) after the frontline modality
failed was significantly higher in the CA group (40%) than in
the SR group (4.7%, p < 0.001) (21). Theoretically, a successful
CA thrombectomy requires firm engagement of a large-bore
catheter distal tip with the occluding clot. In ICAS-related LVO,
the parent artery is likely to be tortuous in form and tapered to
the occlusion site.
Therefore, the distal tip of a large-bore catheter is likely
to less firmly engage the occluding clot in ICAS-related LVO
than the embolic clot in a normal parent artery (Figure 1).
Furthermore, the reocclusion rate of CA thrombectomy was
similar to that of SR thrombectomy (8). In CA thrombectomy,
a microcatheter and a microwire were navigated through the
occlusion site and then a large-bore catheter is advanced over the
wire andmicrocatheter to the occluding clot. Thus, the preceding
passage of a microwire and a microcatheter may also irritate the
inflamed plaque and eventually provoke more platelet activation
in ICAS-related LVO.
Rescue Treatments
As in the embolic LVO, fast and successful recanalization is the
most important factor for achieving good outcomes in ICAS-
related LVO. Therefore, if the primary thrombectomy failed to
achieve recanalization, rescue treatments should be performed
as soon as possible. Rescue treatments after failure of frontline
thrombectomy for LVO include switching to another tool (SR
to CA thrombectomy or vice versa), simultaneous use of both
SR and CA thrombectomies, intraarterial thrombolytic infusion,
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TABLE 1 | Comparison of outcomes between intracranial atherosclerotic stenosis-related and embolic large vessel occlusion.
References Group Recanalization mRS, 0–2 Symptomatic ICH Mortality
Kang et al. (8) ICAS-related 80.0% 65.0% 2.5% NA
Embolic 83.7% 67.5% 5.4% NA
Lee et al. (16) ICAS-related 62.5% 41.7% NA 8.3%
Embolic 63.6% 31.3% NA 24.6%
Jia et al. (18) ICAS-related 95.7% 63.8% 4.3% 12.8%
Embolic 96.8% 51.6% 4.3% 12.9%
Al Kasab et al. (17) ICAS-related *64.7% *42.4% 11.1% 39.4%
Embolic *95.3% *55.8% 9.8% 20.7%
Yoon et al. (15) ICAS-related *95.0% *62.5% 7.5% 15.0%
Embolic *81.8% *38.6% 3.0% 9.1%
Baek et al. (14) ICAS-related 80.4% 46.4% 5.4% 19.6%
Embolic 88.5% 46.9% 5.0% 15.3%
Lee et al. (19) ICAS-related 76.8% 45.5% 7.1 NA
Embolic 79.6% 54.5% 10.7 NA
ICAS, intracranial atherosclerotic stenosis; mRS, modified Rankin Scale score; ICH, intracranial hemorrhage; *, statistically significant.
FIGURE 1 | A schematic drawing of reocclusion mechanism after stent retriever or contact aspiration thrombectomy for intracranial atherosclerotic stenosis-related
large vessel occlusion.
intraarterial, or intravenous glycoprotein IIb/IIIa inhibitor (GPI)
infusion and stenting with or without balloon angioplasty (6–8,
13–15, 18, 23–26). Because reocclusion in ICAS-related LVO is
very frequent and most likely due to platelet activation, a severe
degree of residual stenosis, or combined contribution of both,
rescue treatment should be focused on platelet inhibition and
alleviating the degree of residual stenosis. GPI has been suggested
for platelet inhibition in the several previous reports. Intraarterial
or intravenous infusion of low dose of GPI (Tirofiban, 0.5–1.5mg
or Reopro, 3–10mg) was effective for resolution or prevention of
re-occlusion of ICAS-related LVO (7, 8, 14) (Figure 2). GPI could
make the endothelium more stable, which could reverse the in-
situ thrombotic reocclusion tendency (6, 7, 14, 22). In our center,
intra-procedural administration method of GPI is typically as
follows; angiogram is obtained every 10min at least 2 times after
administration of 0.3–0.5mg of Tirofiban (or Reopro, 3–5mg).
If reocclusion (tendency) is not resolved, additional 0.3–0.5mg
of Tirofiban (or Reopro, 3–5mg) is administered up to 1.5mg
(or Reopro, 10mg) until reocclusion (tendency) is resolved (or
improved antegrade flow velocity) on angiogram obtained every
10min. The dose of GPI did not depend on whether or not to use
intravenous tPA administration.
Rescue stenting and/or angioplasty is an another (or
additional) option for resolving reocclusion. As well known,
a severe degree of focal stenosis is an important factor
that provokes clot formation. Therefore, by alleviating the
underlying severe degree of stenosis, rescue stenting and/or
balloon angioplasty is likely to play a role in preventing
reocclusion or in recanalization for such cases that are never
opened with mechanical thrombectomy (24, 25) (Figure 3).
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FIGURE 2 | A schematic drawing of rescue treatment for reocclusion after initial recanalization of intracranial atherosclerotic stenosis-related large vessel occlusion.
FIGURE 3 | Comparison of modified Rankin scale score among mechanical thrombectomy success, rescue stenting, and non-stenting groups. MT, mechanical
thrombectomy.
In literature, it seemed to depend on operators’ preference
whether to do stent alone, stent with pre- or post-stent
balloon angioplasty, or balloon angioplasty alone (6, 17–19,
24, 25). It also depended on operators’ preference to use what
kind of stent. However, self-expanding stent seemed to be
favored rather than balloon-expandable stent. In addition, of the
self-expanding stent, Solitaire-FR stent rather than Wingspan
stent seemed to be favored for rescue stenting. It is likely
because Wingspan stent requires additional preparation time
and more technical demands for delivery, whereas it seems
simple to detach a Solitaire-FR that was already in using for
thrombectomy (6, 24, 25).
Recent two studies compared patients who received rescue
stenting with those who was left without further treatment after
mechanical thrombectomy failure. Rescue stenting group showed
better functional outcome than non-stenting group (24, 25).
Patients with recanalization success showed a similar distribution
of mRS at 3 months, regardless of recanalization methods
(mechanical thrombectomy or rescue stenting) (Figure 3). In
those studies, the majority of patients with rescue stenting had
ICAS-related LVO. Therefore, rescue stenting may be a rescue
method in ICAS-related LVO. Another recent study also have
demonstrated that both GPI and rescue stenting are similarly
effective and safe in ICAS-related LVO (23).
Postprocedural delayed reocclusion also worsen patients’
functional outcome (25, 26). Timing and maintenance of
postprocedural antiplatelet medication is important to prevent
postprocedural reocclusion. Although there has not been
controlled study, intravenous infusion of GPI with maintenance
dose for a 6–12 h after completion of EVT and then change
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to oral antiplatelet medication has been proposed (14). The
degree of residual stenosis may be an another factor for
post-procedural reocclusion. It has not yet been studied
whether rescue stenting and/or angioplasty is needed to prevent
postprocedural delayed reocclusion. However, if the degree
of stenosis is very severe, alleviating the stenosis by rescue
stenting and/or angioplasty may be helpful in both instant and
delayed reocclusion. It should be addressed if rescue stenting
and/or angioplasty is helpful for preventing postprocedural
delayed reocclusion.
It has yet remained unclear whether stenting combined with
anti-thrombotic drug is safe in acute stroke setting. In recent
reports, however, intracranial or cervical carotid artery stenting
with use of antithrombotic medication in acute stroke setting
did not increase the development of symptomatic intracranial
hemorrhage, while significantly improved functional outcome
(24, 25, 27). Because of retrospective nature of these studies,
the type and mode of antithrombotic medication combined
with stenting varied depending on centers; (1) intra-arterial
or intravenous loading of GPI followed by maintenance of 6–
12 h, then changed to oral dual antiplatelets, (2) loading dose
of oral dual antiplatelets just before or after rescue stenting
(aspirin 85–500mg and clopidogrel 300mg), (3) oral mono
antiplatelet (clopidogrel, 75–300mg), and (4) no antiplatelet
medication until follow-up CT or MR on the next day (24, 27).
When GPI and rescue stenting which requires antithrombotic
medication is applied in acute stroke setting, the most feared
concern is possibly increased risk of intracranial hemorrhage.
In recent multicenter studies, however, intracranial or cervical
carotid stenting combined with use of antithromboics drugs
in acute stroke setting did not increase the development
of symptomatic intracranial hemorrhage whereas significantly
improved functional outcome (24, 25, 27). In our experience,
it seems very helpful in decision making to obtain flat-panel
CT before GPI infusion and/or rescue stenting. Although a
specific criterion of unfavorable candidate for GPI and/or rescue
stenting has not yet been recommended, we have not done
further treatment for cases that have large area of contrast
material enhancement on flat-panel CT. In this strategy, the
rate of symptomatic intracranial hemorrhage was not higher in
patients with GPI and/or rescue stenting than in patients without
(7, 14, 24, 25).
ENDOVASCULAR STRATEGY
APPROPRIATE FOR ICAS-RELATED LVO
Recanalization status and procedural time are more relevant
factors affecting patient outcomes than occlusion etiology. For
faster and more successful recanalization, identifying underlying
ICAS as the cause of LVO and setting an optimal strategy
for ICAS-related LVO are key factors leading to better clinical
outcomes in ICAS-related LVO patients. Before starting EVT, the
following markers may suggest ICAS-related LVO from embolic
LVO: (1) the absence of atrial fibrillation on echocardiogram and
(2) absence of hyperdense artery sign on CT or susceptibility
(blooming) artifact sign on MR gradient echo image, and
(3) truncal-type occlusion on CTA. During the EVT, (1) a
truncal-type occlusion and (2) a remnant (fixed focal) stenosis
after initial recanalization at the occlusion site are suggested
as useful surrogate markers of ICAS-related LVO (Table 2).
It is critical to determine when to introduce what kind of
rescue treatment after failure of mechanical thrombectomy in
ICAS-related LVO. Procedural time in the ICAS-related LVO
was consistently longer than in the embolic group across the
all previous studies (7, 8, 12–16, 20, 21), and this can be
explained by repeat SR or CA thrombectomy attempts before
applying the appropriate rescue treatment for ICAS-related
LVO (7, 12, 14, 19). If the appropriate EVT strategy for
ICAS-related LVO can be set early (before starting EVT, if
possible), operators can shorten the puncture–to-recanalization
(procedural) time as well as increase recanalization rate, thus
providing a better clinical outcome (6, 7, 14, 19). Rescue
stenting and/or balloon angioplasty, intra-arterial or intravenous
GPI infusion, or combination of those have been reported
as appropriate treatments for ICAS thrombo-occlusion (7,
8, 14, 15, 18, 23, 23–25). The stepwise approach in using
such modalities in addition to mechanical thrombectomy is
likely helpful in faster and more successful recanalization of
ICAS-related LVO.
From practical point of view, a microcatheter with inner
diameter 0.021-inch may be less difficult in delivery to the
target lesion of ICAS-related LVO than a large-bore aspiration
catheter because the relevant parent artery is likely more tortuous
in ICAS-related LVO than in embolic LVO. Furthermore, SR
TABLE 2 | Surrogate markers suggested of intracranial atherosclerosis-related
large vessel occlusion.
Surrogate markers ICAS-related Embolic
Before
starting
EVT
Atrial fibrillation, 2017 (13) +* +++
Susceptibility artifact on MR gradient
echo image, 2015 (28)
+ +++
Hyperdense artery sign on NECT,
2017 (29)
+ ++
Truncal-type occlusion on CT
angiography, 2017 (13), 2016 (14)
+++ +
During
the EVT
Truncal-type occlusion, 2016 (7),
2017 (13), 2016 (14)
++++ +
Residual stenosis, 2014 (8), 2015
(16), 2018 (23)
++++ +
EVT, endovascular treatment; ICAS, intracranial atherosclerotic stenosis; MR, magnetic
resonance; NECT, non-enhanced computed tomography; CT, computed tomography.
* The number of+ sign indicates to have more probability to have ICAS-related or embolic
surrogate markers.
TABLE 3 | Comparison between stent retriever and contact aspiration
thrombectomy in practice.
Stent retriever Contact aspiration
Delivery to the target lesion Not difficult Occasionally difficult
Help in differentiation in ICAS-related from
embolic LVO during the procedure (7, 13)*
Yes No
First-pass recanalization success (23) Higher Lower
*, by disclosing occlusion type (truncal-type or branching-site occlusion). Truncal-type is
suggestive of intracranial atherosclerosis related large vessel occlusion.
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FIGURE 4 | The stepwise endovascular strategy appropriate for intracranial atherosclerotic stenosis-related large vessel occlusion. ICAS, intracranial atherosclerotic
stenosis; LVO, large vessel occlusion; GRE-MR, gradient echo magnetic resonance imaging; HAS, hyperdense artery sign; NECT, non-enhanced computed
tomography; TTO, truncal type occlusion; CT, computed tomography; SR, stent retriever; GPI, glycoprotein IIb/IIIa inhibitor.
is better to detect ICAS-related LVO by showing occlusion
type (truncal or branching-site) as well as to obtain first-
pass recanalization (Table 3). Therefore, SR thrombectomy is
recommended as frontline modality if ICAS-related LVO is
suspected. After achieving initial recanalization, a follow-up
angiogram should be obtained every 10min at least up to 30min
for detecting reocclusion (tendency). If reocclusion occurs
with mild-to-moderate degree of residual stenosis after initial
recanalization, GPI should be first recommended for avoiding
acute stenting so far as possible. Whereas, if recanalization is
never obtained or if reocclusion appears due to a severe degree
of residual stenosis, rescue stenting and/or balloon angioplasty
may be considered (Figure 4).
Although there has been no well-controlled study yet, rescue
stenting and/or GPI use may be recommended as a rescue
endovascular strategy appropriate for ICAS-LVO with never
recanalization or repeat reocclusion. A prospective study is
needed to find most appropriate endovascular strategy for ICAS-
related LVO.
CONCLUSIONS
Recanalization success and puncture-to-recanalization
(procedure) time are two important procedural prognostic
factors in ICAS-related LVO. With similar recanalization rate
and procedure time, clinical outcome of ICAS-related LVO
would be comparable to that of embolic LVO. For obtaining
successful recanalization in ICAS-related LVO as fast and
with high rate as in embolic LVO, the specific EVT strategy
appropriate for ICAS is needed.
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